최근 4년간 국내 단일 의료기관을 내원한 소아청소년에서 분리된 폐구균의 항생제 감수성 양상 분석 = Antibiotics Susceptability of Streptococcus pneumoniae Isolated from Single Tertiary Childrens' Hospital Since 2014 and Choice of Appropriate Empirical Antibiotics

다국어 초록 (Multilingual Abstract)

Purpose: We investigated the distribution and antimicrobial resistance of pneumococcal isolates from hospitalized children at Asan Medical Center for recent 4 years, and aimed to recommend proper choice of empirical antibiotics for pneumococcal infection. Methods: From March 2014 to May 2018, children admitted to Asan Medical Center Childrens' Hospital with pneumococcal infection were subjected for evaluation of minimal inhibitory concentration (MIC) for β-lactams and macrolide antibiotics. Patient's age, underlying disease, gender were retrospectively collected. Using Monte Carlo simulation model and MIC from our study, we predicted the rate of treatment success with amoxicillin treatment. Results: Sixty-three isolates were analyzed including 20.6% (n=13) of invasive isolates, and 79.4% (n=50) of non-invasive isolates; median age were 3.3 years old, and 87.3% of the pneumococcal infections occurred to children with underlying disease. Overall susceptibility rate was 49.2%, 68.2%, and 74.6% for amoxicillin, parenteral penicillin, and cefotaxime respectively. 23.8% and 9.5% of the isolates showed high resistance for amoxicillin, and cefotaxime. Only 4.8% (n=3) were susceptible to erythromycin. Monte Carlo simulation model revealed the likelihood of treatment success was 46.0% at the dosage of 90 mg/kg/day of amoxicillin. Conclusions: Recent pneumococcal isolates from pediatric patients with underlying disease revealed high resistance for amoxicillin and cefotaxime, and high resistance for erythromycin. Prudent choice of antibiotics based on the local data of resistance cannot be emphasized enough, especially in high risk patients with underlying disease, and timely vaccination should be implemented for prevention of the spread of resistant strains.

국문 초록 (Abstract)

목적: 최근 4년간 서울아산병원에 내원한 소아청소년에서 분리된 폐구균의 항생제 감수성 양상을 파악하여, 3차 의료기관 내원 환자에서 발생한 폐구균 감염증에서 적절한 경험적 항균 요법을 제시하고자 하였다. 방법: 2014년 3월부터 2018년 5월까지 서울아산병원 어린이병원에 폐구균 감염으로 입원하였던 18세 미만의 환아를 대상으로 연령, 성별, 기저질환 및 폐구균의 β-lactam 및 macrolide 항생제 감수성 양상을 후향적 의무 기록을 통해 조사하였다. Fallon 등이 제시한 Monte Carlo simulation 모델을 이용하여 경구 amoxicillin의 치료 효과를 예측하였다. 결과: 총 63례의 폐구균 감염증이 연구에 포함되었고, 87.3%(55례)는 기저질환이 있는 환아에서 발생하였다. 20.6%(13례) 가 혈액(11례)을 포함한 무균성 체액에서 분리된 침습성 감염증이었으며, 폐구균에 의한 뇌수막염은 발생하지 않았다. Amoxicillin, 정주용 penicillin, cefotaxime 및 erythromycin에 대한 내성률은 각각 50.8%, 31.8%, 25.4% 및 95.2%이었으며, amoxicillin과 cefotaxime에 대한 고도 내성률은 각각 23.8% 및 9.5%이었다. Monte Carlo simulation에 의하면 경구용 amoxicillin을 90 mg/kg/day의 용량으로 투여 시 적절한 치료 효과를 기대할 수 있는 amoxicillin MIC 값은 2.0 µg/mL 이하로서 본 연구에서 포함된 비침습성 폐구균의 46.0%가 이 범위에 속하였다. 결론: 최근 4년간 기저질환을 가진 소아환자에서 분리된 폐구균 중 amoxicillin 및 cefotaxime에 고도 내성을 보이는 균주의 비율이 증가하였으며, erythromycin에 대하여 95% 이상 내성이다. 이에 다양한 기저질환을 동반한 고위험군 환아에서 발생한 폐구균 감염증에서 신중한 경험적 항생제 선택이 필요하겠으며, 침습 감염 및 내성 확산 방지를 위한 적절한 폐구균 백신 접종이 필수적이다.

참고문헌 (Reference)

1 송은경, "소아 침습성 폐구균 감염증의 역학적 특성과 임상 양상" 대한소아감염학회 12 (12): 140-148, 2005

2 염혜영, "세균성 폐렴과 항생제 선택" 대한소아청소년과학회 52 (52): 283-288, 2009

3 백지연, "국내의 소아에서 분리된 폐구균의 항생제 감수성 양상 및 약력동학 모델을 이용한 적절한 항생제의 선택" 대한소아감염학회 18 (18): 109-116, 2011

4 Kim KH, "The causative organisms of bacterial meningitis in Korean children, 1986–1995" 13 : 60-64, 1998

5 Song JH, "Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study" 28 : 1206-1211, 1999

6 Kim SH, "Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing invasive and noninvasive pneumococcal diseases in Korea from 2008 to 2014" 2016 : 6950482-, 2016

7 Cho EY, "Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006–2010" 78 : 481-486, 2014

8 Vuori-Holopainen E, "SE-TU Study Group. Narrow-versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime" 159 : 878-884, 2000

9 orumkuney D, "Results from the survey of antibiotic resistance (SOAR) 2012–14 in Thailand, India, South Korea and Singapore" 71 (71): i3-19, 2016

10 Pallares R, "Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain" 333 : 474-480, 1995

11 Weinstein MP, "Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance" 48 : 1596-1600, 2009

12 Mantese OC, "Prevalence of serotypes and antimicrobial resistance of invasive strains of pneumococcus in children: analysis of 9 years" 85 : 495-502, 2009

13 Brandileone MC, "Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal study group in Brazil for the SIREVA project" 3 : 141-146, 1997

14 Klugman KP, "Pneumococcal resistance to antibiotics" 3 : 171-196, 1990

15 Fallon RM, "Pharmacodynamic target attainment of oral β-lactams for the empiric treatment of acute otitis media in children" 10 : 329-335, 2008

16 Tan TQ, "Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines" 25 : 409-419, 2012

17 Song JH, "Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)" 53 : 457-463, 2004

18 Hyde TB, "Macrolide resistance among invasive Streptococcus pneumoniae isolates" 286 : 1857-1862, 2001

19 Hicks LA, "Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004" 196 : 1346-1354, 2007

20 Song JH, "High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)" 48 : 2101-2107, 2004

21 Yun KW, "Genetic structures of invasive Streptococcus pneumoniae isolates from Korean children obtained between 1995 and 2013" 18 : 268-, 2018

22 Robinson KA, "Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: opportunities for prevention in the conjugate vaccine era" 285 : 1729-1735, 2001

23 Hausdorff WP, "Epidemiological differences among pneumococcal serotypes" 5 : 83-93, 2005

24 Moore MR, "Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?" 46 : 183-185, 2008

25 Song JH, "Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens" 38 : 1570-1578, 2004

26 조은영, "Changes in Serotype Distribution and Antibiotic Resistance of Nasopharyngeal Isolates of Streptococcus pneumoniae from Children in Korea, after Optional Use of the 7-Valent Conjugate Vaccine" 대한의학회 27 (27): 716-722, 2012

27 CLSI, "CLSI document M100-S26" Clinical and Laboratory Standards Institute 2008

28 Doern GV, "Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?" 41 : 139-148, 2005

29 Friedland IR, "Antibiotic-resistant pneumococcal disease in South African children" 146 : 920-923, 1992